DVA DAVITA INC. Insider Trading

CCO James O Hearty sells 15,000 DVA shares at $193.98 for $2.9M, reducing stake 40.1%

James O Hearty, Chief Compliance Officer, conducted an open-market sale of 15,000 shares at $193.98 on 2026-05-15, reducing his holdings from 37,389 shares to 22,389 shares (a 40.1% reduction). This represents a material reduction in his equity position in DVA. The transaction occurred at a time when the company reports positive fundamentals: $3.4B in quarterly revenue, $197.5M in net income, and 6.5% annual revenue growth. The sale follows a prior sell at the same ticker in 2024, though the outcome of that prior transaction is not yet measurable. With only 1 prior sell in his cross-ticker track record, this transaction lacks a statistically meaningful pattern to assess against his historical behavior.

DaVita COO Maughan sells ~$4.1M in stock across two days near recent highs; first open-market sales in 36 months.

David Paul Maughan, DaVita's Chief Operating Officer, executed his first open-market sales in the past three years, disposing of approximately 20,500 shares across two consecutive trading days and raising roughly $4.1 million. The sales occurred while the stock was trading just below its 52-week high, suggesting the executive chose to exit near peak valuation rather than during a pullback. DaVita itself remains profitable with positive revenue growth, so the sales do not appear driven by fundamental deterioration. The magnitude of the transaction—representing a significant portion of Maughan's holdings—marks a notable change from his prior pattern of stock-based compensation activity, making this pivot to active selling worth monitoring to understand whether it reflects personal portfolio rebalancing or carries broader implications for management's outlook.

CFO Joel Ackerman sells 51,471 shares of DaVita for $9.9M, his third open-market sale in 36 months.

Joel Ackerman, DaVita's CFO, sold over $9.8 million in shares, reducing his position by roughly a quarter. This is his third open-market sale in the past three years, continuing a consistent pattern of selling rather than buying. His prior two sales at this company were poorly timed—the stock rose after both exits—yet Ackerman is selling again as the company remains financially sound with consistent profitability and revenue growth. The stock is currently at its 52-week high, having climbed steeply in recent months, which creates a different context than his prior sales occurred in. While the CFO's repeated selling suggests he may be rebalancing a concentrated position rather than signaling fundamental concerns, the uniform pattern of poorly-timed prior exits raises the question of whether this latest sale will prove similarly mistimed or whether selling at the 52-week high reflects better timing than his previous attempts.

Berkshire Hathaway divests ~4% of DVA stake in massive $183M sale; stock near highs on strong fundamentals

Berkshire Hathaway, DVA's largest shareholder, sold over 1.2 million shares in a single transaction, reducing its position by approximately 4%. The stock is trading just below its recent highs while maintaining strong fundamentals—the company is profitable with solid revenue growth and trades at a reasonable valuation multiple. This sale is a portfolio management decision by a major institutional holder rather than a reflection of insider concern; large funds periodically trim positions to rebalance allocations or lock in gains, especially when holdings approach weighting thresholds. The timing, with the stock posting strong momentum and fundamentals intact, is consistent with disciplined rebalancing rather than distress or loss of confidence in the business.